Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BY-NC-NDACR open rheumatology

Impact of Phases of Menstrual Cycle on Patient-Reported Outcomes in Females With Lupus: A Narrative Review.

  • Alexis Roberts1
  • Lillian Sutton2
  • Cathrine Constantacos3
  • Shaketha Gray4
  • Onengiya Harry5,6
6 affiliations
  1. 1University of North Carolina School of Medicine.
  2. 2Department of Endovascular and Vascular Surgery, Wake Forest University School of Medicine.
  3. 3Section of Pediatric Endocrinology, Department of Pediatrics, Wake Forest University School of Medicine, Brenner Children's Hospital.
  4. 4Section of Adolescent Medicine, Department of Pediatrics, Wake Forest University School of Medicine, Brenner Children's Hospital.
  5. 5Section of Pediatric Rheumatology, Department of Pediatrics, Wake Forest University School of Medicine, Brenner Children's Hospital.
  6. 6Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine.
Read full textPDFDOICite

Abstract

The objective of this narrative review is to synthesize existing evidence on menstrual-cycle-associated variation in patient-reported outcomes (PROs) in reproductive-aged women with systemic lupus erythematosus (SLE), integrate comparative findings from disease controls and nondisease controls, identify clinical implications, and indicate directions for future studies. A review of the literature was conducted using PubMed, Medline (Clarivate), JISC Library Hub, PsychINFO, and Web of Science. Inclusion criteria included articles referencing women with SLE, PROs, and menstrual cycle phases. Database research conducted yielded 74 articles with 34 meeting inclusion criteria. Key findings from the review include: (1) biologic plausibility for phase-linked activity: estrogen signaling via type-I IFN pathways amplifies proinflammatory cytokine production whereas progesterone decreases this effect. Premenstrual decline may remove this protection. Furthermore, gene expression and peripheral immune cell phenotypes vary with phases of menstrual cycle. (2) Pattern of symptom fluctuation: across studies, premenstrual and menstrual phases are associated with increased pain, fatigue, and mood disturbances. Several observational cohorts report significant worsening of visual analog score pain or fatigue and disease activity scores during menses compared with postovulatory phases. Rheumatoid arthritis and fibromyalgia (FM) cohorts suggest similar findings; FM shows the largest increase in widespread pain with changes in menstrual cycle. Female athlete studies corroborate cycle-related fluctuations in energy, mood, and pain sensitivity. Menstrual cycle phase is a clinically relevant modulator of impairment to quality of life in reproductive-aged women with SLE. Recognition of cyclical patterns can improve the interpretation of patient-reported outcome measure score, reduce misclassification of flares, and support personalized management strategies. Integration of menstrual phase data into routine clinical assessment and trial design is warranted.

Related

  1. Integrating Real-World Evidence, Patient-Reported Outcomes and Health Economics into Evidence-Based Public Health-A Narrative Review and Conceptual Framework.
    Mariola Borowska, Piotr Bromber, Tomasz Kopiec +5
    Clinics and practicePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Patient-reported and caregiver-reported outcomes in refractory ascites secondary to cirrhosis: A systematic review and meta-analysis
    Yazan Haddadin, James Ryley, Benjaman To +4
    Hepatology communicationsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Intra-Patient Comparison of a Minimally Invasive Lid Treatment and Traditional Blepharoplasty: Patient and Surgeon-Reported Outcomes
    A. C. Victoria, R. E. Roth, M. N. Berkowitz +2
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv
  4. Three-Year Functional Vision, Longitudinal Refractive Outcomes, and Patient-Reported Outcomes After Bilateral Implantation of the Extend Bessel-Optics Intraocular Lens: An Independent Real-World Ambispective Study
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome
    Chanakya Nayudu, Andrew Song, Shruti Chaturvedi
    Blood vessels, thrombosis & hemostasisPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{roberts2026impact,
  title = {{Impact of Phases of Menstrual Cycle on Patient-Reported Outcomes in Females With Lupus: A Narrative Review.}},
  author = {Alexis Roberts and Lillian Sutton and Cathrine Constantacos and Shaketha Gray and Onengiya Harry},
  journal = {ACR open rheumatology},
  year = {2026},
  month = oct,
  doi = {10.1002/acr2.90111},
  url = {https://europepmc.org/article/MED/42904806},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Impact of Phases of Menstrual Cycle on Patient-Reported Outcomes in Females With Lupus: A Narrative Review.
AU  - Alexis Roberts
AU  - Lillian Sutton
AU  - Cathrine Constantacos
AU  - Shaketha Gray
AU  - Onengiya Harry
PY  - 2026
DA  - 2026/10/01
JO  - ACR open rheumatology
DO  - 10.1002/acr2.90111
UR  - https://europepmc.org/article/MED/42904806
AB  - The objective of this narrative review is to synthesize existing evidence on menstrual-cycle-associated variation in patient-reported outcomes (PROs) in reproductive-aged women with systemic lupus erythematosus (SLE), integrate comparative findings from disease controls and nondisease controls, identify clinical implications, and indicate directions for future studies. A review of the literature was conducted using PubMed, Medline (Clarivate), JISC Library Hub, PsychINFO, and Web of Science. Inclusion criteria included articles referencing women with SLE, PROs, and menstrual cycle phases. Database research conducted yielded 74 articles with 34 meeting inclusion criteria. Key findings from the review include: (1) biologic plausibility for phase-linked activity: estrogen signaling via type-I IFN pathways amplifies proinflammatory cytokine production whereas progesterone decreases this effect. Premenstrual decline may remove this protection. Furthermore, gene expression and peripheral immune cell phenotypes vary with phases of menstrual cycle. (2) Pattern of symptom fluctuation: across studies, premenstrual and menstrual phases are associated with increased pain, fatigue, and mood disturbances. Several observational cohorts report significant worsening of visual analog score pain or fatigue and disease activity scores during menses compared with postovulatory phases. Rheumatoid arthritis and fibromyalgia (FM) cohorts suggest similar findings; FM shows the largest increase in widespread pain with changes in menstrual cycle. Female athlete studies corroborate cycle-related fluctuations in energy, mood, and pain sensitivity. Menstrual cycle phase is a clinically relevant modulator of impairment to quality of life in reproductive-aged women with SLE. Recognition of cyclical patterns can improve the interpretation of patient-reported outcome measure score, reduce misclassification of flares, and support personalized management strategies. Integration of menstrual phase data into routine clinical assessment and trial design is warranted.
SN  - 2578-5745
ER  -